This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Douglas LaBrecque: Innovator in Hepatitis C Research
Introduction
Douglas LaBrecque is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of medical research, particularly in the detection and purification of the Hepatitis C virus (HCV). His innovative work has the potential to improve diagnostic methods and treatment options for this viral infection.
Latest Patents
LaBrecque holds 1 patent related to his research on Hepatitis C. His patent, titled "Hepatitis C virus Fc-binding function," focuses on the detection and purification of HCV. The invention exploits a newly discovered Fc-binding function in HCV, allowing for the capture of the virus from infected samples. This advancement enables greatly simplified methods of diagnosis and offers improved treatment options, as well as the first opportunity to purify significant quantities of HCV.
Career Highlights
Douglas LaBrecque is affiliated with the University of Iowa Research Foundation, where he conducts his research. His work has garnered attention for its potential impact on public health and the management of Hepatitis C.
Collaborations
LaBrecque has collaborated with esteemed colleagues in his field, including Jack T Stapleton and Jian-Qiu Han. Their combined expertise contributes to the advancement of research in Hepatitis C and related areas.
Conclusion
Douglas LaBrecque's innovative contributions to Hepatitis C research highlight the importance of scientific inquiry in addressing public health challenges. His work not only enhances diagnostic methods but also paves the way for improved treatment strategies.